Polaris Group (6550.TW)

TWD 38.0

(-5.59%)

Operating Income Summary of Polaris Group

  • Polaris Group's latest annual operating income in 2023 was -1.84 Billion TWD , down -59.57% from previous year.
  • Polaris Group's latest quarterly operating income in 2024 Q2 was -573.92 Million TWD , down -19.16% from previous quarter.
  • Polaris Group reported an annual operating income of -1.15 Billion TWD in 2022, down -58.15% from previous year.
  • Polaris Group reported an annual operating income of -731.91 Million TWD in 2021, down -7.95% from previous year.
  • Polaris Group reported a quarterly operating income of -573.92 Million TWD for 2024 Q2, down -19.16% from previous quarter.
  • Polaris Group reported a quarterly operating income of -597.55 Million TWD for 2023 Q4, down -22.09% from previous quarter.

Annual Operating Income Chart of Polaris Group (2023 - 2016)

Historical Annual Operating Income of Polaris Group (2023 - 2016)

Year Operating Income Operating Income Growth
2023 -1.84 Billion TWD -59.57%
2022 -1.15 Billion TWD -58.15%
2021 -731.91 Million TWD -7.95%
2020 -677.99 Million TWD 14.74%
2019 -795.22 Million TWD 21.55%
2018 -1.01 Billion TWD -20.15%
2017 -843.73 Million TWD 11.01%
2016 -948.16 Million TWD 0.0%

Peer Operating Income Comparison of Polaris Group

Name Operating Income Operating Income Difference
Apex Biotechnology Corp. 141.71 Million TWD 1403.344%
Sinphar Pharmaceutical Co.,Ltd. 286.05 Million TWD 745.694%
Panion & Bf Biotech Inc. 156.82 Million TWD 1277.746%
Chunghwa Chemical Synthesis & Biotech Co., Ltd. 280.8 Million TWD 757.759%
GenMont Biotech Incorporation 6.98 Million TWD 26531.697%
Abnova (Taiwan) Corporation 47.19 Million TWD 4013.733%
Adimmune Corporation -722.74 Million TWD -155.559%
Tanvex BioPharma, Inc. -2.1 Billion TWD 12.077%
Energenesis Biomedical CO.,LTD. -261.83 Million TWD -605.419%
UnicoCell Biomed Co., Ltd. -96.28 Million TWD -1818.412%
PELL Bio-Med Technology Co. Ltd. -411.24 Million TWD -349.134%